Drugs News and Research

RSS

SRI awarded DOE grant to expand MetaCyc database and enhance Pathway Tools software

SRI International, an independent nonprofit research and development organization, announced today it has been awarded a grant by the Department of Energy (DOE) to expand its MetaCyc database and enhance its Pathway Tools software. This project will give SRI's bioinformatics tools even greater utility in the emerging area of bioenergy, or renewable energy derived from biological sources.

27 Jan 2011

Nanoencapsulation helps administer more-effective doses of anti-cancer drugs

Scientists are reporting successful application of the technology used in home devices to clean jewelry, dentures, and other items to make anticancer drugs like tamoxifen and paclitaxel dissolve more easily in body fluids, so they can better fight the disease. The process, described in ACS' journal, Langmuir, can make other poorly soluble materials more soluble, and has potential for improving the performance of dyes, paints, rust-proofing agents and other products.

27 Jan 2011

Medisafe to develop barcoded system to confirm origin of prescription medications

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to begin development of a barcoded system to confirm the origin and authenticity of prescription medications. The product is aimed at reducing ingestion of counterfeit medications.

27 Jan 2011

Roundup: Calif. regulator gets emergency approval to oversee insurance spending; Ariz. seeks Medicaid waiver

Governors have deep differences over national health care reform, but when it comes to so-called insurance exchanges — a centerpiece of the sprawling new federal law — nearly every state is moving ahead with implementation.

27 Jan 2011

Researchers discover new sensory neurons that mediate BP and metabolism regulation in liver

For 60 years, scientists have puzzled over the possibility of a hepatic osmoreceptor that influences blood pressure regulation. Now, researchers of the Max Delbr-ck Center for Molecular Medicine Berlin-Buch, the Experimental and Clinical Research Center of the MDC and Charit- and the Hannover Medical School appear to have made a breakthrough discovery.

27 Jan 2011

Targeting UROD enzyme boosts effects of radiotherapy and chemotherapy in head, neck tumors

Cancer researchers at Princess Margaret Hospital (PMH) have discovered that targeting an enzyme called Uroporphyrinogen Decarboxylase (UROD) can sensitize diseased tissue to radiation and chemotherapy, which could mean fewer side effects for individuals with head and neck cancer.

27 Jan 2011

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2010.

27 Jan 2011

Quest Diagnostics releases new data on oral fluid testing system

OraSure Technologies, the market leader in oral fluid diagnostics, announced today that Quest Diagnostics Incorporated released new data indicating that oral fluid revealed approximately five times more heroin use in the general U.S. workforce than previously believed.

From Quest Diagnostics 27 Jan 2011

Teva announces acquisition of Corporación Infarmasa

Teva Pharmaceutical Industries Ltd. announced today the acquisition of Corporación Infarmasa, a top ten pharmaceutical company in Perú, from The Rohatyn Group and Altra Investments.

27 Jan 2011

WSJ: Biotech generics battle heats up

A battle is heating up over the meaning of a single word in the health overhaul that could mean billions of dollars to the makers of biotechnology drugs (Mundy, 1/26).

27 Jan 2011

Six key points to tackle substance abuse, addiction problems among nurses

As many as ten to 20 per cent of nurses and nursing students may have substance abuse and addiction problems, but the key to tackling this difficult issue - and protecting public safety - is support and treatment, not punishment. That is the key message in a paper in the February issue of the Journal of Clinical Nursing.

27 Jan 2011

CyDex stockholders approve merger with Ligand

CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.

27 Jan 2011

First Edition: January 26, 2011

Reporting for KHN, in collaboration with Politico, Bara Vaida writes: "Lobbyists for doctors, hospitals and drug companies are urging lawmakers to derail a planned government panel that health industry officials fear will sharply curb Medicare spending -- a critical revenue source for them".

26 Jan 2011

Ligand announces acquisition of CyDex Pharmaceuticals

Ligand Pharmaceuticals Incorporated today announced it has acquired privately held CyDex Pharmaceuticals, for a combination of cash and contingent payments.

26 Jan 2011

Pill for multiple sclerosis in the pipeline

Multiple Sclerosis or MS is a severely disabling disease that affects 100,000 in the UK. Now a new pill has been developed to treat multiple sclerosis which means there would be no need for injections. European health experts - European Medicines Agency (EMA) have given the new drug Gilenya, the brand name for the drug fingolimod, approval which would grant it EU wide acceptance.

25 Jan 2011

Evaluating patients for genetic variations impacts adherence to antiviral therapy

In two recent studies, researchers have identified two functional variants in the inosine triphosphatase (ITPA) gene that protect patients with hepatitis C virus (HCV) against anemia brought on by antiviral treatment. The ability to identify those patients protected against treatment-induced anemia will ensure completion of antiviral therapy and successful elimination of the virus.

25 Jan 2011

NINDS awards AndroScience $3.8M cooperative translational research grant for Kennedy's Disease

AndroScience Corp., based in San Diego, California, announced receiving a $3.8 Million, 3-year milestone-driven, cooperative translational research grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH).

25 Jan 2011

Scientist receives grant for research on parasitic diseases through African biodiversity medicines

McGill University and McGill University scientist Dr. Timothy Geary received a $1-million grant today for landmark research into addressing parasitic diseases through medicines derived from African biodiversity.

25 Jan 2011

Scientists to develop enzyme that protects against nerve agents

Protection against nerve gas attack is a significant component of the defense system of many countries around the world. Nerve gases are used by armies and terrorist organizations, and constitute a threat to both the military and civilian populations, but existing drug solutions against them have limited efficiency.

25 Jan 2011

Glioblastoma's molecular flexibility helps resist nearly all treatment efforts

Glioblastoma, the most common and lethal form of brain cancer and the disease that killed Massachusetts Senator Ted Kennedy, resists nearly all treatment efforts, even when attacked simultaneously on several fronts. One explanation can be found in the tumor cells' unexpected flexibility, discovered researchers at the Salk Institute for Biological Studies.

25 Jan 2011

Drugs News and Research

SRI awarded DOE grant to expand MetaCyc database and enhance Pathway Tools software

Nanoencapsulation helps administer more-effective doses of anti-cancer drugs

Medisafe to develop barcoded system to confirm origin of prescription medications

Roundup: Calif. regulator gets emergency approval to oversee insurance spending; Ariz. seeks Medicaid waiver

Researchers discover new sensory neurons that mediate BP and metabolism regulation in liver

Targeting UROD enzyme boosts effects of radiotherapy and chemotherapy in head, neck tumors

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Quest Diagnostics releases new data on oral fluid testing system

Teva announces acquisition of Corporación Infarmasa

WSJ: Biotech generics battle heats up

Six key points to tackle substance abuse, addiction problems among nurses

CyDex stockholders approve merger with Ligand

First Edition: January 26, 2011

Ligand announces acquisition of CyDex Pharmaceuticals

Pill for multiple sclerosis in the pipeline

Evaluating patients for genetic variations impacts adherence to antiviral therapy

NINDS awards AndroScience $3.8M cooperative translational research grant for Kennedy's Disease

Scientist receives grant for research on parasitic diseases through African biodiversity medicines

Scientists to develop enzyme that protects against nerve agents

Glioblastoma's molecular flexibility helps resist nearly all treatment efforts

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News